Skip Navigation LinksHome > January/February 2014 - Volume 39 - Issue 1 > Spinal Epidural Hematoma After Spinal Cord Stimulator Trial...
Regional Anesthesia & Pain Medicine:
doi: 10.1097/AAP.0000000000000029
Case Reports

Spinal Epidural Hematoma After Spinal Cord Stimulator Trial Lead Placement in a Patient Taking Aspirin

Buvanendran, Asokumar MD; Young, Adam C. MD

Collapse Box


Objective: Spinal epidural hematoma is a rare, but potentially devastating, consequence of accessing the epidural space for anesthesia or interventional pain procedures. There is no consensus to stop aspirin therapy before interventional chronic pain procedures.

Case Report: A 73-year-old woman with postlaminectomy pain syndrome and lumbar radiculopathy underwent percutaneous spinal cord stimulator lead placement. She had been taking aspirin 81 mg/d for several years. Twenty-four hours later, she developed an epidural hematoma. Prompt recognition and surgical management resulted in no long-term neurological sequelae.

Conclusions: The only variable that could have led to our patient’s epidural hematoma is aspirin. This is the first reported case of aspirin leading to an epidural hematoma following an interventional chronic pain procedure. Prior to interventional pain procedures, one should contemplate cessation of aspirin therapy because there are, at present, no consensus guidelines to direct such a decision.

Copyright © 2014 by American Society of Regional Anesthesia and Pain Medicine.


Article Tools


Article Level Metrics